.

Our Expert Team

This innovative diagnostic process was created after hallway conversations between physicians led us to strive toward a better solution to diagnostic reporting. We believe the result can benefit health care providers throughout the country by improving care, eliminating waste and strengthening collaboration.

Our leadership team includes:

Mary Zutter, M.D.

Mary Zutter, M.D.

  • Assistant Vice Chancellor for Integrative Diagnostics
  • Director, Tumor-Host Interaction Program, Vanderbilt Ingram Cancer Center
  • Scientific Director, Human Tissue Acquisition & Pathology Core

 

Madan Jagasia, M.D., M.B.B.S., M.S.

Madan Jagasia, M.D., M.B.B.S., M.S.

  • Associate Professor of Medicine
  • Chief, Section of Hematology-Stem Cell Transplant
  • Director, Outpatient Transplant Program

 

Samuel Santoro, M.D., Ph.D.

Samuel Santoro, M.D., Ph.D.

  • Professor and Chair, Department of Pathology, Microbiology and Immunology

 

Michael Laposata, M.D., Ph.D.

Michael Laposata, M.D., Ph.D.

  • Pathologist-in-Chief, Vanderbilt University Hospital
  • Executive Vice Chairman, Dept. of Pathology
  • Director of Clinical Laboratories

 

Adam Seegmiller, M.D, Ph.D.

Adam Seegmiller, M.D, Ph.D.

  • Assistant Professor, Department of Pathology, Microbiology and Immunology
  • Director, Hematopathology Division
  • Director, Immunopathology Laborator

 

William Pao, M.D., Ph.D.

William Pao, M.D., Ph.D.

  • Director, Division of Hematology/Oncology
  • Director, Personalized Cancer Medicine
  • Professor of Medicine, Cancer Biology and Pathology

 

William Stead, M.D.

William Stead, M.D.

  • Associate Vice Chancellor for Health Affairs
  • Chief Strategy & Information Officer

 

Mia Levy, M.D., Ph.D.

Mia Levy, M.D., Ph.D.

  • Ingram Assistant Professor of Cancer Research
  • Assistant Professor of Biomedical Informatics and Medicine
  • Director Cancer Clinical Informatics, Vanderbilt Ingram Cancer Center

 



 

This page was last updated July 30, 2013 and is maintained by